Отдаленные результаты применения pl-VEGF 165 при хронической ишемии нижних конечностей вследствие облитерирующего атеросклероза

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• pCMV-vegf165 Intramuscular Gene Transfer is an Effective Method of Treatment for Patients With Chronic Lower Limb Ischemia

  2015cited by this paper
• VEGF-VEGFR Signals in Health and Disease

  2014cited by this paper
• Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.

  2013cited by this paper
• Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia.

  2012cited by this paper
• Phase I/IIa Clinical Trial of Therapeutic Angiogenesis Using Hepatocyte Growth Factor Gene Transfer to Treat Critical Limb Ischemia

  2011cited by this paper
• Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.

  2010cited by this paper
• Meta-analysis of randomized, controlled clinical trials in angiogenesis: gene and cell therapy in peripheral arterial disease

  2009cited by this paper
• Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer

  2009cited by this paper
• Human studies of angiogenic gene therapy.

  2009cited by this paper
• Treatment with Intramuscular Vascular Endothelial Growth Factor Gene Compared with Placebo for Patients with Diabetes Mellitus and Critical Limb Ischemia: A Double-Blind Randomized Trial

  2006cited by this paper

• STATIONARY-SUBSTITUTE TECHNOLOGIES IN THE TREATMENT OF PATIENTS WITH ULCEROUS-NECROTIC CHANGES IN CRITICAL ISCHEMIA OF LOWER

  2019cites this paper